413 related articles for article (PubMed ID: 17785329)
21. [Evaluation of simultaneous detection of specific antinuclear antibodies using multiplexed technology].
Uto K; Hayashi N; Kinoshita S; Kawano S; Kumagai S
Rinsho Byori; 2009 Oct; 57(10):941-53. PubMed ID: 19928490
[TBL] [Abstract][Full Text] [Related]
22. From ANA to ENA: how to proceed?
Damoiseaux JG; Tervaert JW
Autoimmun Rev; 2006 Jan; 5(1):10-7. PubMed ID: 16338206
[TBL] [Abstract][Full Text] [Related]
23. How should a district general hospital immunology service screen for anti-nuclear antibodies? An 'in-the-field' audit.
Hira-Kazal R; Shea-Simonds P; Peacock JL; Maher J
Clin Exp Immunol; 2015 Apr; 180(1):52-7. PubMed ID: 25412573
[TBL] [Abstract][Full Text] [Related]
24. Second generation analysis of antinuclear antibody (ANA) by combination of screening and confirmatory testing.
Scholz J; Grossmann K; Knütter I; Hiemann R; Sowa M; Röber N; Rödiger S; Schierack P; Reinhold D; Bogdanos DP; Meroni PL; Radice A; Conrad K; Roggenbuck D
Clin Chem Lab Med; 2015 Nov; 53(12):1991-2002. PubMed ID: 26020561
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of an automated chemiluminescent immunoassay kit for antinuclear antibodies in autoimmune diseases.
Zafrir Y; Gilburd B; Carrasco MG; Kivity S; Sánchez-Castañón M; López-Hoyos M; Mandel M; Szmyrka M; Shoenfeld Y; Agmon-Levin N
Immunol Res; 2013 Jul; 56(2-3):451-6. PubMed ID: 23579775
[TBL] [Abstract][Full Text] [Related]
26. Can an ELISA replace immunofluorescence for the detection of anti-nuclear antibodies?--The routine use of anti-nuclear antibody screening ELISAs.
Sinclair D; Saas M; Williams D; Hart M; Goswami R
Clin Lab; 2007; 53(3-4):183-91. PubMed ID: 17447656
[TBL] [Abstract][Full Text] [Related]
27. [Performance and clinical evaluation of antinuclear antibody test based on fluorescence enzyme immunoassay].
Watanabe N; Nagatomo R; Okubo S; Yokota H; Ikeda H; Yatomi Y
Rinsho Byori; 2014 Apr; 62(4):315-23. PubMed ID: 25022060
[TBL] [Abstract][Full Text] [Related]
28. Detection of antinuclear antibodies by indirect immunofluorescence and by solid phase assay.
Op De Beeck K; Vermeersch P; Verschueren P; Westhovens R; Mariën G; Blockmans D; Bossuyt X
Autoimmun Rev; 2011 Oct; 10(12):801-8. PubMed ID: 21741497
[TBL] [Abstract][Full Text] [Related]
29. Clinical utility of screening for antinuclear antibodies by enzyme immunoassay--a preliminary study.
Divate S; Hardikar P; Bichile LS; Rajadhyaksha A
J Assoc Physicians India; 2004 Apr; 52():290-3. PubMed ID: 15636329
[TBL] [Abstract][Full Text] [Related]
30. [Comparison of the methods used for the detection of antinuclear antibodies].
Berkem R; Gümüş T; Karakoç E; Acar N
Mikrobiyol Bul; 2003; 37(2-3):171-8. PubMed ID: 14593900
[TBL] [Abstract][Full Text] [Related]
31. Pattern on the antinuclear antibody-HEp-2 test is a critical parameter for discriminating antinuclear antibody-positive healthy individuals and patients with autoimmune rheumatic diseases.
Mariz HA; Sato EI; Barbosa SH; Rodrigues SH; Dellavance A; Andrade LE
Arthritis Rheum; 2011 Jan; 63(1):191-200. PubMed ID: 20954189
[TBL] [Abstract][Full Text] [Related]
32. The initial manifestations and final diagnosis of patients with high and low titers of antinuclear antibodies after 6 months of follow-up.
Wang KY; Yang YH; Chuang YH; Chan PJ; Yu HH; Lee JH; Wang LC; Chiang BL
J Microbiol Immunol Infect; 2011 Jun; 44(3):222-8. PubMed ID: 21524618
[TBL] [Abstract][Full Text] [Related]
33. [Detection of anti-SSA/Ro antibody by ELISA, double immunodiffusion, and immunoblotting: a comparative study].
Tong SQ; Shi Q; Wen XH; Gan XD; Shi YP; Zhao Y; Zeng XF; Zhang FC; Dong Y
Zhonghua Yi Xue Za Zhi; 2006 Sep; 86(35):2455-7. PubMed ID: 17156670
[TBL] [Abstract][Full Text] [Related]
34. Antinuclear antibodies (ANA) screening by enzyme immunoassay with nuclear HEp-2 cell extract and recombinant antigens: analytical and clinical evaluation.
González C; Guevara P; Alarcón I; Hernando M; Navajo JA; González-Buitrago JM
Clin Biochem; 2002 Sep; 35(6):463-9. PubMed ID: 12413607
[TBL] [Abstract][Full Text] [Related]
35. Automated antinuclear immunofluorescence antibody screening: a comparative study of six computer-aided diagnostic systems.
Bizzaro N; Antico A; Platzgummer S; Tonutti E; Bassetti D; Pesente F; Tozzoli R; Tampoia M; Villalta D;
Autoimmun Rev; 2014 Mar; 13(3):292-8. PubMed ID: 24220268
[TBL] [Abstract][Full Text] [Related]
36. [Detection of anti-nuclear antibodies in liver diseases by indirect immunofluorescence method and enzyme-linked immunosorbent assay].
Koizumi H; Onozuka Y; Shibata M; Sano K; Oosima Y; Miyachi K; Ueno Y
Rinsho Byori; 1999 Aug; 47(8):744-8. PubMed ID: 10511806
[TBL] [Abstract][Full Text] [Related]
37. A comparative study on the reliability of an automated system for the evaluation of cell-based indirect immunofluorescence.
Melegari A; Bonaguri C; Russo A; Luisita B; Trenti T; Lippi G
Autoimmun Rev; 2012 Aug; 11(10):713-6. PubMed ID: 22269861
[TBL] [Abstract][Full Text] [Related]
38. [An immunoenzymatic technique for the detection of antinuclear antibodies].
Meriche H; Meriche-Gadiri S; Ghaffor M; Abbadi MC
Ann Biol Clin (Paris); 2000; 58(6):711-4. PubMed ID: 11098167
[TBL] [Abstract][Full Text] [Related]
39. ICARE improves antinuclear antibody detection by overcoming the barriers preventing accreditation.
Bertin D; Mouhajir Y; Bongrand P; Bardin N
Clin Chim Acta; 2016 Feb; 454():57-61. PubMed ID: 26742604
[TBL] [Abstract][Full Text] [Related]
40. Diagnostic value of screening methods for the determination of antinuclear antibodies using indirect immunofluorescence on HEp-2 cells and enzyme immunoassay in autoimmune liver diseases.
Dorofeev AS; Aleksandrova EN; Novikov AA; Saliev KG; Sandler YG; Vinnitskaya EV
Klin Lab Diagn; 2022 Nov; 67(11):652-657. PubMed ID: 36398774
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
